| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
N/A |
| Shares
Out: |
26,519,000 |
| Market
Cap: |
19.89(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.55 - $1.89 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile VolitionRx is an epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop blood tests to help diagnose and monitor a range of life-altering diseases including certain cancers and diseases associated with NETosis such as sepsis and COVID-19. Co.'s tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Co. is primarily focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
109,000 |
210,422 |
938,911 |
| Total Buy Value |
$0 |
$81,200 |
$210,662 |
$1,612,569 |
| Total People Bought |
0 |
5 |
11 |
12 |
| Total Buy Transactions |
0 |
9 |
21 |
38 |
| Total Shares Sold |
0 |
40,000 |
40,000 |
54,949 |
| Total Sell Value |
$0 |
$33,000 |
$33,000 |
$69,924 |
| Total People Sold |
0 |
1 |
1 |
2 |
| Total Sell Transactions |
0 |
2 |
2 |
3 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Innes Guy Archibald |
|
– • – |
2023-11-27 |
4 |
B |
$0.77 |
$15,400 |
D/D |
20,000 |
627,161 |
0.01 |
- |
|
| Innes Guy Archibald |
|
– • – |
2023-11-24 |
4 |
B |
$0.76 |
$7,600 |
D/D |
10,000 |
607,161 |
0.01 |
- |
|
| Innes Guy Archibald |
|
– • – |
2023-11-22 |
4 |
B |
$0.71 |
$14,200 |
D/D |
20,000 |
597,161 |
0.01 |
- |
|
| Butera Salvatore Thomas |
CEO - Volition Veterinary |
• – – |
2023-11-16 |
4 |
B |
$0.81 |
$8,100 |
D/D |
10,000 |
79,350 |
0.01 |
- |
|
| Hughes Terig |
Chief Financial Officer |
• – – |
2023-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
285,740 |
|
- |
|
| Gaetan Michel |
Chief Operating Officer |
• – – |
2023-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
297,585 |
|
- |
|
| Faulkes Martin Charles |
Executive Director |
• • – |
2023-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
1,717,682 |
|
- |
|
| Reynolds Cameron John |
President and CEO |
• • – |
2023-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
1,694,518 |
|
- |
|
| Gaetan Michel |
Chief Operating Officer |
• – – |
2023-10-04 |
4 |
D |
$0.68 |
$10,403 |
D/D |
(15,412) |
197,585 |
|
- |
|
| Butera Salvatore Thomas |
CEO - Volition Veterinary |
• – – |
2023-10-04 |
4 |
D |
$0.68 |
$3,938 |
D/D |
(5,834) |
178,873 |
|
- |
|
| Forterre Gael |
Chief Commercial Officer |
• – – |
2023-10-04 |
4 |
D |
$0.68 |
$3,731 |
D/D |
(5,527) |
102,251 |
|
- |
|
| Faulkes Martin Charles |
|
– • – |
2023-10-04 |
4 |
D |
$0.68 |
$3,949 |
D/D |
(5,850) |
1,667,682 |
|
- |
|
| Barnes Phillip |
|
– • – |
2023-09-05 |
4 |
B |
$1.30 |
$6,500 |
D/D |
5,000 |
24,686 |
0.01 |
- |
|
| Henshall Mickie |
|
– • – |
2023-08-31 |
4 |
B |
$1.25 |
$4,633 |
D/D |
3,706 |
18,706 |
0.01 |
- |
|
| Faulkes Martin Charles |
|
– • – |
2023-08-31 |
4 |
B |
$1.28 |
$12,436 |
D/D |
9,716 |
1,673,532 |
0.01 |
- |
|
| Micallef Jacob Vincent |
Chief Scientific Officer |
• – – |
2023-08-30 |
4 |
B |
$1.27 |
$11,113 |
I/I |
8,750 |
55,000 |
0.01 |
- |
|
| Micallef Jacob Vincent |
Chief Scientific Officer |
• – – |
2023-08-29 |
4 |
B |
$1.24 |
$13,950 |
I/I |
11,250 |
46,250 |
0.01 |
- |
|
| Micallef Jacob Vincent |
Chief Scientific Officer |
• – – |
2023-08-25 |
4 |
B |
$1.24 |
$24,800 |
D/D |
20,000 |
235,140 |
0.01 |
- |
|
| Futcher Edward |
|
– • – |
2023-08-24 |
4 |
B |
$1.22 |
$6,100 |
D/D |
5,000 |
62,936 |
0.01 |
- |
|
| Kway Jasmine |
CEO - Singapore Volition |
• – – |
2023-08-24 |
4 |
B |
$1.20 |
$6,000 |
I/I |
5,000 |
10,400 |
0.01 |
- |
|
| Gaetan Michel |
Chief Operating Officer |
• – – |
2023-08-24 |
4 |
B |
$1.23 |
$6,150 |
D/D |
5,000 |
212,997 |
0.01 |
- |
|
| Butera Salvatore Thomas |
CEO - Volition Veterinary |
• – – |
2023-08-16 |
4 |
B |
$1.21 |
$9,680 |
D/D |
8,000 |
69,350 |
0.01 |
- |
|
| Reynolds Cameron John |
President and CEO |
• • – |
2023-08-16 |
4 |
B |
$1.22 |
$12,200 |
D/D |
10,000 |
1,494,518 |
0.01 |
- |
|
| Faulkes Martin Charles |
|
– • – |
2023-08-03 |
4 |
D |
$1.30 |
$7,055 |
D/D |
(5,427) |
1,663,816 |
|
- |
|
| Micallef Jacob Vincent |
Chief Scientific Officer |
• – – |
2023-08-03 |
4 |
D |
$1.30 |
$7,055 |
D/D |
(5,427) |
215,140 |
|
- |
|
305 Records found
|
|
Page 2 of 13 |
|
|
0.13 (14.53%) 
